Neutralizing Antibodies to SARS-CoV-2
A high-throughput test that can predict neutralizing activities is a critical step toward understanding herd immunity to covid-19.
Read MorePosted by Laurie Bonner | Jan 15, 2021 | Uncategorized |
A high-throughput test that can predict neutralizing activities is a critical step toward understanding herd immunity to covid-19.
Read MorePosted by Melanie Hamilton-Basich | Jan 12, 2021 | Covid 19, Flu & Respiratory Infections, POC Rapid Assays |
QuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read MorePosted by Melanie Hamilton-Basich | Jan 11, 2021 | Cancer, Digital Imaging |
With Concentriq, LabPON gains added flexibility to scale its routine digital pathology operations as the total number of worldwide cancer cases continues to rise.
Read MorePosted by Laurie Bonner | Jan 8, 2021 | Compliance, Covid 19, Molecular Diagnostics |
The FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests.
Read MorePosted by Laurie Bonner | Jan 8, 2021 | Clinical Chemistry Test Kits, Covid 19 |
Siemens Healthineers’ Advia Centaur Interleukin-6 test can be used to determine the risk of mechanical ventilation for hospitalized covid-19 patients.
Read More